This week on Pharm5:
- Stem cell transplant led to HIV remission
- Pyrukynd approved for PK-deficient hemolytic anemia
- TicoVac recommended for tick-borne encephalitis
- New PBM regulation passed in Michigan
- FTC fails to pass PBM investigation proposal
Connect with us!
- Listen to our podcast: Pharm5
- Watch us on TikTok: @LizHearnPharmD
- Follow us on Twitter: @LizHearnPharmD
References:
- HIV: Stem cell transplant may have cured woman. Medical News Today. https://www.medicalnewstoday.com/articles/stem-cell-treatment-may-have-cured-woman-of-hiv#Not-a-universal-cure. Accessed February 24, 2022.
- FDA approvals roundup: Pyrukynd and Solosec. Regulatory Affairs Professionals Society (RAPS). https://www.raps.org/news-and-articles/news-articles/2022/2/fda-approvals-roundup-pyrukynd-nalmefene-hcl-solos. Accessed February 24, 2022.
- Pyrukynd [package insert]. U.S. Food and Drug Administration Website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216196s000lbl.pdf. Revised February 2022.
- CDC Advisory Committee on Immunization Practices Votes to recommend ticovac™, Pfizer's tick-borne encephalitis (TBE) vaccine, for those at risk of virus exposure. Pfizer. https://www.pfizer.com/news/press-release/press-release-detail/cdc-advisory-committee-immunization-practices-votes. Accessed February 24, 2022.
- Morgan LW, Knowles EP, 17 F. Michigan Pharmacy Benefit Manager (PBM) Bill Passes the Senate. Frier Levitt - Attorneys at Law. https://www.frierlevitt.com/articles/michigan-pharmacy-benefit-manager-pbm-bill-passes-the-senate/. Published February 17, 2022. Accessed February 24, 2022.
- Barrett J. PBM reform legislation progresses in Michigan. Drug Topics. https://www.drugtopics.com/view/pbm-reform-legislation-progresses-in-michigan. Published March 26, 2021. Accessed February 24, 2022.
- Pharmacypracticenews.com. https://www.pharmacypracticenews.com/Online-First/Article/02-22/FTC-Votes-Against-Investigating-PBMs-Effects-on-Specialty-Pharmacies/66213. Accessed February 24, 2022.
- Rowland D. Federal Trade Commission rejects Pharmacy Benefit Managers Probe pushed by Biden appointee. The Columbus Dispatch. https://www.dispatch.com/story/news/2022/02/17/prescription-drug-costs-ftc-declines-go-after-pbms-despite-pharmacists-testimony/6787109001/. Published February 18, 2022. Accessed February 24, 2022.
